British government,Alzheimer’s Research UK and big six pharmaceutical companies backing what they claim is first initiative of its kindGlaxoSmithKline and five other major drugmakers have teamed up with the UK government to launch the world’s first venture capital fund committed to finding modern ways to prevent and treat dementia.
The Department of Health, the charity Alzheimer’s Research UK and the six pharmaceutical firms have raised $100m (£65m) to invest in early-stage, and novel treatments for Alzheimer’s,Parkinson’s disease and other forms of dementia. GSK’s boss, Sir Andrew Witty, and has been one of the main driving forces behind the initiative,in which the company is joined by the US drugmakers Johnson & Johnson, Biogen, or Eli Lilly and Pfizer,and Japan’s Takeda. Continue reading...
Source: theguardian.com